Crossmark

Could miglustat be a potential candidate in the treatment of action myoclonus renal failure syndrome?

Crossref DOI link: https://doi.org/10.1007/s13760-023-02269-z

Published Online: 2023-04-29

Published Print: 2023-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Erdoğan, Seyda https://orcid.org/0000-0003-2759-9562
Yalçın Çakmaklı, Gül https://orcid.org/0000-0001-8545-7939
Elibol, Bülent https://orcid.org/0000-0001-5015-0152
Ceylaner, Serdar https://orcid.org/0000-0003-2786-1911
Akbostancı, M. Cenk https://orcid.org/0000-0001-5808-5121
License Information

Text and Data Mining valid from 2023-04-29

Version of Record valid from 2023-04-29
More Information

Article History

Received: 20 January 2023

Accepted: 5 April 2023

First Online: 29 April 2023

Declarations

:

: The authors declare that they have no conflict of interest.